Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomark Prev. 2016;25(1):16–27.
Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, Kerlikowske K, Miglioretti DL: Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2014, 106(10).
Colin C, Schott AM. Re: Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst. 2011;103(1):77.
Institute of Medicine Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer: The National Academies Collection: Reports funded by National Institutes of Health. In: Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis: A Breast Cancer Research Foundation and Institute of Medicine Symposium. edn. Edited by Herdman R, Norton L. Washington (DC): National Academies Press (US) National Academy of Sciences.; 2005.
Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, Vachon C, Bakker MF, Giles GG, Chia KS, et al. Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014, 106(5).
Patterson SK, Roubidoux MA. Update on new technologies in digital mammography. Int J Women’s Health. 2014;6:781–8.
Balleyguier C, Ayadi S, Van Nguyen K, Vanel D, Dromain C, Sigal R. BIRADS classification in mammography. Eur J Radiol. 2007;61(2):192–4.
Jeffreys M, Harvey J, Highnam R. Comparing a new volumetric breast density method (VolparaTM) to cumulus. Edited by Joan Martí, Arnau Oliver, Jordi Freixenet, and Robert Martí. In: Digital mammography: 2010/2010. Berlin: Springer; 2010. pp 408–413.
Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative-analysis of mammographic densities. Phys Med Biol. 1994;39(10):1629–38.
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, et al. Mammographic density and the risk and detection of breast cancer. New Engl J Med. 2007;356(3):227–36.
Fletcher SW, Elmore JG. Clinical practice. Mammographic screening for breast cancer. New Engl J Med. 2003;348(17):1672–80.
Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 2002;225(1):165–175
Bae MS, Moon WK, Chang JM, Koo HR, Kim WH, Cho N, Yi A, Yun BL, Lee SH, Kim MY, et al. Breast cancer detected with screening US: reasons for nondetection at mammography. Radiology. 2014;270(2):369–77.
Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, et al. Heritability of mammographic density, a risk factor for breast cancer. New Engl J Med. 2002;347(12):886–94.
Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976;37(5):2486–92.
Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol. 1976;126(6):1130–7.
Krook PM. Mammographic parenchymal patterns as risk indicators for incident cancer in a screening program: an extended analysis. AJR Am J Roentgenol. 1978;131(6):1031–5.
Egan RL, Mosteller RC. Breast cancer mammography patterns. Cancer. 1977;40(5):2087–90.
Threatt B, Norbeck JM, Ullman NS, Kummer R, Roselle P. Association between mammographic parenchymal pattern classification and incidence of breast cancer. Cancer. 1980;45(10):2550–6.
Egan RL, McSweeney MB. Mammographic parenchymal patterns and risk of breast cancer. Radiology. 1979;133(1):65–70.
Moskowitz M, Gartside P, McLaughlin C. Mammographic patterns as markers for high-risk benign breast disease and incident cancers. Radiology. 1980;134(2):293–5.
Tabar L, Dean PB. Mammographic parenchymal patterns. Risk indicator for breast cancer? JAMA. 1982;247(2):185–9.
Witt I, Hansen HS, Brunner S. The risk of developing breast cancer in relation to mammography findings. Eur J Radiol. 1984;4(1):65–7.
Gravelle IH, Bulstrode JC, Bulbrook RD, Hayward JL, Wang DY. The relation between radiological patterns of the breast and body weight and height. Br J Radiol. 1982;55(649):23–5.
Thurfjell E, Hsieh CC, Lipworth L, Ekbom A, Adami HO, Trichopoulos D. Breast size and mammographic pattern in relation to breast cancer risk. Eur J Cancer Prev. 1996;5(1):37–41.
Ciatto S, Zappa M. A prospective study of the value of mammographic patterns as indicators of breast cancer risk in a screening experience. Eur J Radiol. 1993;17(2):122–5.
Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). Cancer Causes Control. 1995;6(5):431–8.
Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87(21):1622–9.
de Stavola BL, Gravelle IH, Wang DY, Allen DS, Bulbrook RD, Fentiman IS, Hayward JL, Chaudary MC. Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol. 1990;19(2):247–54.
Saftlas AF, Wolfe JN, Hoover RN, Brinton LA, Schairer C, Salane M, Szklo M. Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol. 1989;129(3):518–26.
Sala E, Warren R, McCann J, Duffy S, Day N, Luben R. Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme. J Med Screen. 1998;5(4):207–12.
Salminen TM, Saarenmaa IE, Heikkila MM, Hakama M. Is a dense mammographic parenchymal pattern a contraindication to hormonal replacement therapy? Acta Oncol (Stockholm, Sweden). 2000;39(8):969–72.
Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN. Mammographic densities and risk of breast cancer. Cancer. 1991;67(11):2833–8.
Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995;87(9):670–5.
McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159–69.
Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst. 2010;102(16):1224–37.
Ursin G, Lillie EO, Lee E, Cockburn M, Schork NJ, Cozen W, Parisky YR, Hamilton AS, Astrahan MA, Mack T. The relative importance of genetics and environment on mammographic density. Cancer Epidemiol Biomark Prev. 2009;18(1):102–12.
Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomark Prev. 2005;14(2):343–9.
del Carmen MG, Halpern EF, Kopans DB, Moy B, Moore RH, Goss PE, Hughes KS. Mammographic breast density and race. AJR Am J Roentgenol. 2007;188(4):1147–50.
Heller SL, Hudson S, Wilkinson LS. Breast density across a regional screening population: effects of age, ethnicity and deprivation. Br J Radiol. 1055;2015(88):20150242.
Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomark Prev. 2003;12(4):332–8.
Castello A, Ascunce N, Salas-Trejo D, Vidal C, Sanchez-Contador C, Santamarina C, Pedraz-Pingarron C, Moreno MP, Perez-Gomez B, Lope V, et al. Association between western and Mediterranean dietary patterns and mammographic density. Obstet Gynecol. 2016;128(3):574–81.
Nagata C, Matsubara T, Fujita H, Nagao Y, Shibuya C, Kashiki Y, Shimizu H. Associations of mammographic density with dietary factors in Japanese women. Cancer Epidemiol Biomark Prev. 2005;14(12):2877–80.
Quandt Z, Flom JD, Tehranifar P, Reynolds D, Terry MB, McDonald JA. The association of alcohol consumption with mammographic density in a multiethnic urban population. BMC Cancer. 1094;2015:15.
Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst. 2003;95(1):30–7.
Titus-Ernstoff L, Tosteson AN, Kasales C, Weiss J, Goodrich M, Hatch EE, Carney PA. Breast cancer risk factors in relation to breast density (United States). Cancer Causes Control. 2006;17(10):1281–90.
Chen FP, Cheung YC, Soong YK. Factors that influence changes in mammographic density with postmenopausal hormone therapy. Taiwan J Obst Gynecol. 2010;49(4):413–8.
Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004;96(8):621–8.
Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, Forbes JF, Warren RM. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case–control study. J Natl Cancer Inst. 2011;103(9):744–52.
Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz V, Visscher D, Norman A, Couch F, Shepherd J, Fan B, et al. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res BCR. 2013;15(6):R104.
Sartor H, Zackrisson S, Elebro K, Hartman L, Borgquist S. Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer. Cancer Causes Control. 2015;26(6):931–9.
Theocharis AD, Skandalis SS, Neill T, Multhaupt HA, Hubo M, Frey H, Gopal S, Gomes A, Afratis N, Lim HC, et al. Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta. 2015;1855(2):276–300.
Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy LC, Roughley PJ, Watson PH. Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol. 2000;192(3):313–20.
Insua-Rodriguez J, Oskarsson T. The extracellular matrix in breast cancer. Adv Drug Deliv Rev. 2016;97:41–55.
Kauppila S, Stenback F, Risteli J, Jukkola A, Risteli L. Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol. 1998;186(3):262–8.
Carey SP, Martin KE, Reinhart-King CA. Three-dimensional collagen matrix induces a mechanosensitive invasive epithelial phenotype. Sci Rep. 2017;7:42088.
Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res. 2003;5(5):R129–35.
Cho A, Howell VM, Colvin EK. The extracellular matrix in epithelial ovarian cancer—a piece of a puzzle. Front Oncol. 2015;5:245.
Fang X, Balgley BM, Wang W, Park DM, Lee CS. Comparison of multidimensional shotgun technologies targeting tissue proteomics. Electrophoresis. 2009;30(23):4063–70.
Yang WT, Lewis MT, Hess K, Wong H, Tsimelzon A, Karadag N, Cairo M, Wei C, Meric-Bernstam F, Brown P, et al. Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density. Breast Cancer Res Treat. 2010;119(2):305–14
Khan QJ, Kimler BF, O’Dea AP, Zalles CM, Sharma P, Fabian CJ. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Res. 2007;9(3):R35.
Chew GL, Huo CW, Huang D, Hill P, Cawson J, Frazer H, Hopper JL, Haviv I, Henderson MA, Britt K, et al. Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density. Breast Cancer Res Treat. 2015;153(1):89–99.
Hawes D, Downey S, Pearce CL, Bartow S, Wan P, Pike MC, Wu AH. Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res. 2006;8(2):R24.
DeFilippis RA, Chang H, Dumont N, Rabban JT, Chen YY, Fontenay GV, Berman HK, Gauthier ML, Zhao J, Hu D, et al. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov. 2012;2(9):826–39.
DeFilippis RA, Fordyce C, Patten K, Chang H, Zhao J, Fontenay GV, Kerlikowske K, Parvin B, Tlsty TD. Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic density. Can Res. 2014;74(18):5032–44.
Okello J, Kisembo H, Bugeza S, Galukande M. Breast cancer detection using sonography in women with mammographically dense breasts. BMC Med Imaging 2014;14(1)
Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, Pisano ED, Jong RA, Evans WP, Morton MJ, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151–63.
Tagliafico A, Tagliafico G, Astengo D, Cavagnetto F, Rosasco R, Rescinito G, Monetti F, Calabrese M. Mammographic density estimation: one-to-one comparison of digital mammography and digital breast tomosynthesis using fully automated software. Eur Radiol. 2012;22(6):1265–70.
Haas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology. 2013;269(3):694–700.
Roy LD, Dillon LM, Zhou R, Moore LJ, Livasy C, El-Khoury JM, Puri R, Mukherjee P. A tumor specific antibody to aid breast cancer screening in women with dense breast tissue. Genes Cancer. 2017. https://doi.org/10.18632/genesandcancer.134:1-14.
Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med. 2014;20(6):332–42.
Roy LD, Zhou R, Dillon L, Moore LJ, Puri R, Marks JR, Lyerly HK, Mukherjee P. A monoclonal antibody with exceptional specificity across major breast cancer subtypes. In: ASCO San Antonio Breast Cancer Symposium: 2015; San Antonio, Texas; 2015.
Is There a National Reporting Standard? [http://densebreast-info.org/is-there-a-federal-law.aspx]. Accessed 13 Feb 2018.
Clinic M: Breast density—the four levels. In. mayoclinic.org: Mayo Clinic (1998–2018).